Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2013 (2013), Article ID 985636, 6 pages
http://dx.doi.org/10.1155/2013/985636
Research Article

The Protective Effect of Cordymin, a Peptide Purified from the Medicinal Mushroom Cordyceps sinensis, on Diabetic Osteopenia in Alloxan-Induced Diabetic Rats

1Department of Orthopedics, Xi Jing Hospital, The Fourth Military Medical University, Xi’an 710032, China
2The Surgery Department of 520th Hospital of PLA, Mian Yang 621000, China

Received 17 August 2013; Accepted 23 August 2013

Academic Editor: Bo Cui

Copyright © 2013 Wei Qi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. X. Zhang, P. Shi, S. Cao, H. Yu, J. Azad, and S. Ling, “Expression changes of transforming growth factor-beta1 and thrombospondin-1 in cavernous tissues of diabetic rats,” Urologia Internationalis, vol. 84, no. 2, pp. 221–225, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. F. J. Del Canizo Gomez, C. Fernandez Perez, I. Moreno Ruiz et al., “Microvascular complications and risk factors in patients with type 2 diabetes,” Endocrinología y Nutrición, vol. 58, no. 4, pp. 163–168, 2011. View at Publisher · View at Google Scholar
  3. B. Lu, W. Gong, Z. Yang et al., “An evaluation of the diabetic kidney disease definition in chinese patients diagnosed with type 2 diabetes mellitus,” The Journal of International Medical Research, vol. 37, no. 5, pp. 1493–1500, 2009. View at Google Scholar · View at Scopus
  4. H. Atsumi, M. Kitada, K. Kanasaki, and D. Koya, “Reversal of redox-dependent inhibition of diacylglycerol kinase by antioxidants in mesangial cells exposed to high glucose,” Molecular Medicine Reports, vol. 4, no. 5, pp. 923–927, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. M. Yamamoto, T. Yamaguchi, M. Yamauchi, H. Kaji, and T. Sugimoto, “Diabetic patients have an increased risk of vertebral fractures independent of BMD or diabetic complications,” Journal of Bone and Mineral Research, vol. 24, no. 4, pp. 702–709, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. T. Miazgowski, S. Pynka, M. Noworyta-Zietara, B. Kryzanowska-Świniarska, and R. Pikul, “Bone mineral density and hip structural analysis in type 1 diabetic men,” European Journal of Endocrinology, vol. 156, no. 1, pp. 123–127, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. P. Vestergaard, “Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes-a meta-analysis,” Osteoporosis International, vol. 18, no. 4, pp. 427–444, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. T. W. Balon, A. P. Jasman, and J. Zhu, “A fermentation product of Cordyceps sinensis increases whole-body insulin sensitivity in rats,” Journal of Alternative and Complementary Medicine, vol. 8, no. 3, pp. 315–323, 2002. View at Google Scholar · View at Scopus
  9. J. H. Koh, J. M. Kim, U. J. Chang, and H. J. Suh, “Hypocholesterolemic effect of hot-water extract from mycelia of Cordyceps sinensis,” Biological and Pharmaceutical Bulletin, vol. 26, no. 1, pp. 84–87, 2003. View at Publisher · View at Google Scholar · View at Scopus
  10. W. Qi, Y. B. Yan, P. J. Wang, and W. Lei, “The co-effect of Cordyceps sinensis and strontium on osteoporosis in ovariectomized osteopenic rats,” Biological Trace Element Research, vol. 141, no. 1–3, pp. 216–223, 2010. View at Google Scholar
  11. J. H. Wong, T. B. Ng, H. Wang et al., “Cordymin, an antifungal peptide from the medicinal fungus Cordyceps militaris,” Phytomedicine, vol. 18, no. 5, pp. 387–392, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. O. A. Bessy, O. H. Lowry, and M. J. Brock, “A method for the rapid determination of alkaline phosphatase with five cubic millimetres of serum,” Journal of Biological Chemistry, vol. 164, pp. 321–329, 1946. View at Google Scholar
  13. P. Godkar, “Enzymes,” in Textbook of Medical Laboratory Techniques, pp. 149–167, Bhalani Publishing House, Mumbai, India, 1994. View at Google Scholar
  14. D. W. Laight, P. T. Gunnarsson, A. V. Kaw, E. E. Änggård, and M. J. Carrier, “Physiological microassay of plasma total antioxidant status in a model of endothelial dysfunction in the rat following experimental oxidant stress in vivo,” Environmental Toxicology and Pharmacology, vol. 7, no. 1, pp. 27–31, 1999. View at Publisher · View at Google Scholar · View at Scopus
  15. N. P. Botushanov and M. M. Orbetzova, “Bone mineral density and fracture risk in patients with type 1 and type 2 diabetes mellitus,” Folia Medica, vol. 51, no. 4, pp. 12–17, 2009. View at Google Scholar · View at Scopus
  16. P. Vestergaard, L. Rejnmark, and L. Mosekilde, “Diabetes and its complications and their relationship with risk of fractures in type 1 and 2 diabetes,” Calcified Tissue International, vol. 84, no. 1, pp. 45–55, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. L. A. Ahmed, R. M. Joakimsen, G. K. Berntsen, V. Fønnebø, and H. Schirmer, “Diabetes mellitus and the risk of non-vertebral fractures: the Tromsø study,” Osteoporosis International, vol. 17, no. 4, pp. 495–500, 2006. View at Google Scholar
  18. E. A. Thorndike and A. S. Turner, “In search of an animal model for postmenopausal diseases,” Frontiers in Bioscience, vol. 3, pp. c17–c26, 1998. View at Google Scholar · View at Scopus
  19. B. Portha, O. Blondel, P. Serradas et al., “The rat models of non-insulin dependent diabetes induced by neonatal streptozotocin,” Diabete et Metabolisme, vol. 15, no. 2, pp. 61–75, 1989. View at Google Scholar · View at Scopus
  20. K. Sakurai, M. Katoh, K. Someno, and Y. Fujimoto, “Apoptosis and mitochondrial damage in INS-1 cells treated with alloxan,” Biological and Pharmaceutical Bulletin, vol. 24, no. 8, pp. 876–882, 2001. View at Publisher · View at Google Scholar · View at Scopus
  21. Y. Hamada, H. Fujii, and M. Fukagawa, “Histomorphometric analysis of diabetic osteopenia in streptozotocin-induced diabetic mice: role of oxidative stress in diabetic bone disorder,” Bone, vol. 45, supplement 1, pp. S35–S38, 2009. View at Publisher · View at Google Scholar
  22. L. M. Havill, L. G. Hale, D. E. Newman, S. M. Witte, and M. C. Mahaney, “Bone ALP and OC reference standards in adult baboons (Papio hamadryas) by sex and age,” Journal of Medical Primatology, vol. 35, no. 2, pp. 97–105, 2006. View at Publisher · View at Google Scholar · View at Scopus
  23. P. D. Ross and W. Knowlton, “Rapid bone loss is associated with increased levels of biochemical markers,” Journal of Bone and Mineral Research, vol. 13, no. 2, pp. 297–302, 1998. View at Publisher · View at Google Scholar · View at Scopus
  24. G. Patrick, E. Sornay-Rendu, B. Claustrat, and P. D. Delmas, “Biochemical markers of bone turnover, endogenous hormones and the risk of fractures in postmenopausal women: the OFELY study,” Journal of Bone and Mineral Research, vol. 15, no. 8, pp. 1526–1536, 2000. View at Google Scholar · View at Scopus
  25. P. D. Ross, B. C. Kress, R. E. Parson, R. D. Wasnich, K. A. Armour, and I. A. Mizrahi, “Serum bone alkaline phosphatase and calcaneus bone density predict fractures: a prospective study,” Osteoporosis International, vol. 11, no. 1, pp. 76–82, 2000. View at Publisher · View at Google Scholar · View at Scopus